Home » Topics » BioWorld Science

BioWorld Science
RSS

Farnesoid X receptor agonist EYP-001 safe and well tolerated in HBV-infected patients

April 23, 2018

FDA approves intravenous Akynzeo

April 23, 2018

Primary endpoint not met in Arpeggio study of laquinimod in primary progressive multiple sclerosis

April 23, 2018

Patient enrollment ongoing in phase I study of ANX-007 in primary open-angle glaucoma

April 23, 2018

Novel calpain inhibitors identified at Blade Therapeutics

April 23, 2018

Daiichi Sankyo discovers novel proto-oncogene tyrosine-protein kinase receptor Ret inhibitors

April 23, 2018

First efficacy and safety data presented from the RESTORE-IMI 1 phase III trial

April 23, 2018

EMA grants orphan drug designation for ABO-202 gene therapy program in Batten disease

April 23, 2018

Sichuan Kelun-Biotech Biopharmaceutical discovers new FXR agonists

April 23, 2018

Novel CFTR modulators divulged by Vertex Pharmaceuticals

April 23, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...